Hepassocin as a treatment for fulminant hepatic failure: will it translate from rats to human?
Calvaruso
Vincenza
V
Gastroenterologia & Epatologia, DIBIMIS, Università di Palermo, Piazza delle Cliniche 2, 90127 Palermo, Italy. vcalvaruso@libero.it
D000818:Animals; D004195:Disease Models, Animal; D005340:Fibrinogen; D006801:Humans; D017114:Liver Failure, Acute / Q000188:drug therapy*; D009363:Neoplasm Proteins / Q000627:therapeutic use*; D051381:Rats; D011994:Recombinant Proteins / Q000627:therapeutic use; D013045:Species Specificity; D057170:Translational Research, Biomedical
C485894:FGL1 protein, human; D009363:Neoplasm Proteins; D011994:Recombinant Proteins; D005340:Fibrinogen